Timothy A. Springer, Founder, Cambridge, Massachusetts, United States — verified investor profile. See portfolio, sector focus and contact routes.
Timothy A. Springer is a Harvard Medical School professor of biological chemistry and molecular pharmacology who serves as an angel investor and founder of multiple biotechnology companies, including the Institute for Protein Innovation[2][4]. His investment thesis focuses exclusively on early-stage biotech ventures in the Cambridge, Massachusetts area, leveraging his deep expertise in immunology and cell adhesion molecules to identify therapeutic opportunities[1][2]. Springer typically makes substantial founding commitments, such as his initial $5 million investment in Moderna in 2010, where he acted as a lead founder providing one-third of the company’s founding capital[1][7]. His notable portfolio includes Moderna, Scholar Rock, Morphic Therapeutic, and Selecta Biosciences, all of which are publicly traded biotech firms he founded or backed early[1][3]. He is known for a distinctive point of view that combines rigorous scientific discovery with entrepreneurial execution, having started six companies that are all financially successful[7]. While he does not publish formal investment memos, his public interviews emphasize the critical role of foundational science in driving biotec
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Cambridge when building a target list.
Investors like Timothy A. Springer · Full investor directory · Investor access · Company funding database